Listed

Tarsus Pharmaceuticals, Inc.

TARSNasdaqCIK 1819790HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$173.9m, Q2 FY2026
Operating income−$19.9m, Q2 FY2026
Net income−$18.6m, Q2 FY2026
Tarsus Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1.9Revenue, Q3 FY2023, three months to 2023-09-30$1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure13.1Revenue, Q4 FY2023, three months to 2023-12-31$13.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure27.6Revenue, Q1 FY2024, three months to 2024-03-31$27.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure40.8Revenue, Q2 FY2024, three months to 2024-06-30$40.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure48.1Revenue, Q3 FY2024, three months to 2024-09-30$48.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure66.4Revenue, Q4 FY2024, three months to 2024-12-31$66.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure78.3Revenue, Q1 FY2025, three months to 2025-03-31$78.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure103Revenue, Q2 FY2025, three months to 2025-06-30$102.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure119Revenue, Q3 FY2025, three months to 2025-09-30$118.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure152Revenue, Q4 FY2025, three months to 2025-12-31$151.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure162Revenue, Q1 FY2026, three months to 2026-03-31$162.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure174Revenue, Q2 FY2026, three months to 2026-06-30$173.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reported5.2Cost of revenue, Q1 FY2025, three months to 2025-03-31$5.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure6.2Cost of revenue, Q2 FY2025, three months to 2025-06-30$6.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figurenot reportednot reported9.4Cost of revenue, Q1 FY2026, three months to 2026-03-31$9.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure12.1Cost of revenue, Q2 FY2026, three months to 2026-06-30$12.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Research and development$m12.1Research and development, Q3 FY2023, three months to 2023-09-30$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure13.3Research and development, Q4 FY2023, three months to 2023-12-31$13.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure12.1Research and development, Q1 FY2024, three months to 2024-03-31$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure12.3Research and development, Q2 FY2024, three months to 2024-06-30$12.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure12.1Research and development, Q3 FY2024, three months to 2024-09-30$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure16.9Research and development, Q4 FY2024, three months to 2024-12-31$16.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure14.4Research and development, Q1 FY2025, three months to 2025-03-31$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure15.6Research and development, Q2 FY2025, three months to 2025-06-30$15.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure16.3Research and development, Q3 FY2025, three months to 2025-09-30$16.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure18.0Research and development, Q4 FY2025, three months to 2025-12-31$18.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure22.4Research and development, Q1 FY2026, three months to 2026-03-31$22.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure31.0Research and development, Q2 FY2026, three months to 2026-06-30$31.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Selling, general and administrative$mnot reportednot reported51.6Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$51.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure58.8Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$58.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure57.9Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$57.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure69.0Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$69.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure85.0Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$85.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure103Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$103.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure109Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$108.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure131Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$130.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure136Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$136.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure151Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$150.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Operating income$m(40.9)Operating income, Q3 FY2023, three months to 2023-09-30−$40.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure(44.5)Operating income, Q4 FY2023, three months to 2023-12-31−$44.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(37.7)Operating income, Q1 FY2024, three months to 2024-03-31−$37.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure(33.3)Operating income, Q2 FY2024, three months to 2024-06-30−$33.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure(25.2)Operating income, Q3 FY2024, three months to 2024-09-30−$25.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure(24.4)Operating income, Q4 FY2024, three months to 2024-12-31−$24.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(26.3)Operating income, Q1 FY2025, three months to 2025-03-31−$26.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure(22.2)Operating income, Q2 FY2025, three months to 2025-06-30−$22.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure(14.5)Operating income, Q3 FY2025, three months to 2025-09-30−$14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure(8.0)Operating income, Q4 FY2025, three months to 2025-12-31−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(6.1)Operating income, Q1 FY2026, three months to 2026-03-31−$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure(19.9)Operating income, Q2 FY2026, three months to 2026-06-30−$19.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Interest expense$m0.9Interest expense, Q3 FY2023, three months to 2023-09-30$858.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-09, accession 0001819790-23-000080.Report this figure1.0Interest expense, Q4 FY2023, three months to 2023-12-31$989.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-27, accession 0001819790-24-000018. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2024, three months to 2024-03-31$983.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-08, accession 0001819790-24-000063.Report this figure2.1Interest expense, Q2 FY2024, three months to 2024-06-30$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure2.4Interest expense, Q3 FY2024, three months to 2024-09-30$2.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure2.3Interest expense, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure2.2Interest expense, Q1 FY2025, three months to 2025-03-31$2.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure2.2Interest expense, Q2 FY2025, three months to 2025-06-30$2.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure2.3Interest expense, Q3 FY2025, three months to 2025-09-30$2.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure2.2Interest expense, Q4 FY2025, three months to 2025-12-31$2.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure2.1Interest expense, Q1 FY2026, three months to 2026-03-31$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure2.2Interest expense, Q2 FY2026, three months to 2026-06-30$2.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-09, accession 0001819790-23-000080.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reported0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figurenot reportednot reported2.4Income tax, Q1 FY2026, three months to 2026-03-31$2.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure2.7Income tax, Q2 FY2026, three months to 2026-06-30$2.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Net income$m(39.1)Net income, Q3 FY2023, three months to 2023-09-30−$39.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure(41.9)Net income, Q4 FY2023, three months to 2023-12-31−$41.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(35.7)Net income, Q1 FY2024, three months to 2024-03-31−$35.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure(33.3)Net income, Q2 FY2024, three months to 2024-06-30−$33.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure(23.4)Net income, Q3 FY2024, three months to 2024-09-30−$23.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure(23.1)Net income, Q4 FY2024, three months to 2024-12-31−$23.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(25.1)Net income, Q1 FY2025, three months to 2025-03-31−$25.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure(20.3)Net income, Q2 FY2025, three months to 2025-06-30−$20.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure(12.6)Net income, Q3 FY2025, three months to 2025-09-30−$12.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure(8.4)Net income, Q4 FY2025, three months to 2025-12-31−$8.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(7.0)Net income, Q1 FY2026, three months to 2026-03-31−$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure(18.6)Net income, Q2 FY2026, three months to 2026-06-30−$18.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Diluted EPS$ per share(1.28)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figurenot reported(1.01)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure(0.88)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure(0.61)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figurenot reported(0.64)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure(0.48)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure(0.30)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figurenot reported(0.16)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure(0.43)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Basic EPS$ per share(1.28)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figurenot reported(1.01)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure(0.88)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure(0.61)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figurenot reported(0.64)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure(0.48)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure(0.30)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figurenot reported(0.16)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure(0.43)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure

Balance sheet

Cash and equivalents$204.6m, Q2 FY2026
Long-term debt$72.8m, Q2 FY2026
Shareholders' equity$346.7m, Q2 FY2026
Tarsus Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m227Cash and equivalents, Q3 FY2023, at 2023-09-30$226.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001819790-23-000080.Report this figure225Cash and equivalents, FY2023, at 2023-12-31$224.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-25, accession 0001819790-25-000011.Report this figure194Cash and equivalents, Q1 FY2024, at 2024-03-31$193.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001819790-24-000063.Report this figure181Cash and equivalents, Q2 FY2024, at 2024-06-30$181.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001819790-24-000111.Report this figure176Cash and equivalents, Q3 FY2024, at 2024-09-30$176.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure94.8Cash and equivalents, FY2024, at 2024-12-31$94.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-23, accession 0001819790-26-000019.Report this figure176Cash and equivalents, Q1 FY2025, at 2025-03-31$175.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure96.6Cash and equivalents, Q2 FY2025, at 2025-06-30$96.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure113Cash and equivalents, Q3 FY2025, at 2025-09-30$112.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure184Cash and equivalents, FY2025, at 2025-12-31$183.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure102Cash and equivalents, Q1 FY2026, at 2026-03-31$102.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure205Cash and equivalents, Q2 FY2026, at 2026-06-30$204.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Current assets$m259Current assets, Q3 FY2023, at 2023-09-30$259.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001819790-23-000080.Report this figure256Current assets, FY2023, at 2023-12-31$256.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0001819790-25-000011.Report this figure341Current assets, Q1 FY2024, at 2024-03-31$340.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001819790-24-000063.Report this figure363Current assets, Q2 FY2024, at 2024-06-30$362.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001819790-24-000111.Report this figure357Current assets, Q3 FY2024, at 2024-09-30$357.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure357Current assets, FY2024, at 2024-12-31$356.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-23, accession 0001819790-26-000019.Report this figure481Current assets, Q1 FY2025, at 2025-03-31$480.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure474Current assets, Q2 FY2025, at 2025-06-30$474.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure502Current assets, Q3 FY2025, at 2025-09-30$501.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure523Current assets, FY2025, at 2025-12-31$522.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure537Current assets, Q1 FY2026, at 2026-03-31$537.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure562Current assets, Q2 FY2026, at 2026-06-30$562.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Total assets$m268Total assets, Q3 FY2023, at 2023-09-30$268.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001819790-23-000080.Report this figure265Total assets, FY2023, at 2023-12-31$265.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0001819790-25-000011.Report this figure349Total assets, Q1 FY2024, at 2024-03-31$349.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001819790-24-000063.Report this figure377Total assets, Q2 FY2024, at 2024-06-30$376.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001819790-24-000111.Report this figure376Total assets, Q3 FY2024, at 2024-09-30$376.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure377Total assets, FY2024, at 2024-12-31$377.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-23, accession 0001819790-26-000019.Report this figure501Total assets, Q1 FY2025, at 2025-03-31$500.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure495Total assets, Q2 FY2025, at 2025-06-30$495.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure535Total assets, Q3 FY2025, at 2025-09-30$534.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure562Total assets, FY2025, at 2025-12-31$562.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure581Total assets, Q1 FY2026, at 2026-03-31$581.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure611Total assets, Q2 FY2026, at 2026-06-30$611.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Current liabilities$m23.2Current liabilities, Q3 FY2023, at 2023-09-30$23.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001819790-23-000080.Report this figure36.9Current liabilities, FY2023, at 2023-12-31$36.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0001819790-25-000011.Report this figure42.5Current liabilities, Q1 FY2024, at 2024-03-31$42.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001819790-24-000063.Report this figure51.6Current liabilities, Q2 FY2024, at 2024-06-30$51.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001819790-24-000111.Report this figure65.9Current liabilities, Q3 FY2024, at 2024-09-30$65.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure80.6Current liabilities, FY2024, at 2024-12-31$80.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-23, accession 0001819790-26-000019.Report this figure86.3Current liabilities, Q1 FY2025, at 2025-03-31$86.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure90.3Current liabilities, Q2 FY2025, at 2025-06-30$90.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure117Current liabilities, Q3 FY2025, at 2025-09-30$117.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure136Current liabilities, FY2025, at 2025-12-31$135.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure144Current liabilities, Q1 FY2026, at 2026-03-31$143.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure176Current liabilities, Q2 FY2026, at 2026-06-30$175.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Total liabilities$m54.7Total liabilities, Q3 FY2023, at 2023-09-30$54.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001819790-23-000080.Report this figure68.5Total liabilities, FY2023, at 2023-12-31$68.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0001819790-25-000011.Report this figure74.1Total liabilities, Q1 FY2024, at 2024-03-31$74.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001819790-24-000063.Report this figure125Total liabilities, Q2 FY2024, at 2024-06-30$124.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001819790-24-000111.Report this figure139Total liabilities, Q3 FY2024, at 2024-09-30$138.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure152Total liabilities, FY2024, at 2024-12-31$152.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-23, accession 0001819790-26-000019.Report this figure158Total liabilities, Q1 FY2025, at 2025-03-31$158.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure162Total liabilities, Q2 FY2025, at 2025-06-30$162.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure199Total liabilities, Q3 FY2025, at 2025-09-30$199.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure219Total liabilities, FY2025, at 2025-12-31$218.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure232Total liabilities, Q1 FY2026, at 2026-03-31$232.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure264Total liabilities, Q2 FY2026, at 2026-06-30$264.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Long-term debt$m29.7Long-term debt, Q3 FY2023, at 2023-09-30$29.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-09, accession 0001819790-23-000080.Report this figure29.8Long-term debt, FY2023, at 2023-12-31$29.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-25, accession 0001819790-25-000011.Report this figure29.9Long-term debt, Q1 FY2024, at 2024-03-31$29.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-08, accession 0001819790-24-000063.Report this figure71.6Long-term debt, Q2 FY2024, at 2024-06-30$71.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0001819790-24-000111.Report this figure71.7Long-term debt, Q3 FY2024, at 2024-09-30$71.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure71.8Long-term debt, FY2024, at 2024-12-31$71.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-23, accession 0001819790-26-000019.Report this figure72.0Long-term debt, Q1 FY2025, at 2025-03-31$72.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure72.1Long-term debt, Q2 FY2025, at 2025-06-30$72.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure72.3Long-term debt, Q3 FY2025, at 2025-09-30$72.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure72.4Long-term debt, FY2025, at 2025-12-31$72.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure72.6Long-term debt, Q1 FY2026, at 2026-03-31$72.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure72.8Long-term debt, Q2 FY2026, at 2026-06-30$72.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure
Shareholders' equity$m214Shareholders' equity, Q3 FY2023, at 2023-09-30$213.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure197Shareholders' equity, FY2023, at 2023-12-31$197.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-23, accession 0001819790-26-000019.Report this figure275Shareholders' equity, Q1 FY2024, at 2024-03-31$275.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure252Shareholders' equity, Q2 FY2024, at 2024-06-30$252.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure237Shareholders' equity, Q3 FY2024, at 2024-09-30$237.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure225Shareholders' equity, FY2024, at 2024-12-31$224.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure342Shareholders' equity, Q1 FY2025, at 2025-03-31$342.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure333Shareholders' equity, Q2 FY2025, at 2025-06-30$332.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure335Shareholders' equity, Q3 FY2025, at 2025-09-30$335.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure343Shareholders' equity, FY2025, at 2025-12-31$343.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure349Shareholders' equity, Q1 FY2026, at 2026-03-31$349.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure347Shareholders' equity, Q2 FY2026, at 2026-06-30$346.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure

Cash flow

Operating cash flow$61.2m, Q2 FY2026
Capital expenditure$4.1m, Q2 FY2026
Tarsus Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(32.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$32.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001819790-24-000129. Derived: 9-month figure less the 6-month figure.Report this figure(39.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$39.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(37.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$37.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure(14.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001819790-25-000108. Derived: 6-month figure less the 3-month figure.Report this figure(8.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001819790-25-000121. Derived: 9-month figure less the 6-month figure.Report this figure(22.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$22.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(20.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$20.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure(29.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$29.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001819790-26-000064. Derived: 6-month figure less the 3-month figure.Report this figure18.3Operating cash flow, Q3 FY2025, three months to 2025-09-30$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001819790-25-000121. Derived: 9-month figure less the 6-month figure.Report this figure19.3Operating cash flow, Q4 FY2025, three months to 2025-12-31$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(24.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$24.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure61.2Operating cash flow, Q2 FY2026, three months to 2026-06-30$61.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001819790-26-000064. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$375.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001819790-24-000129. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$174.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure1.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001819790-25-000108. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$282.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001819790-25-000121. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$72.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$590.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure1.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001819790-26-000064. Derived: 6-month figure less the 3-month figure.Report this figure1.9Capital expenditure, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001819790-25-000121. Derived: 9-month figure less the 6-month figure.Report this figure6.4Capital expenditure, Q4 FY2025, three months to 2025-12-31$6.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-23, accession 0001819790-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure5.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure4.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$4.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001819790-26-000064. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)43.39m, Q2 FY2026
Tarsus Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares26.7Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3026,662,374 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001819790-23-000080.Report this figure26.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3126,742,023 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001819790-24-000063.Report this figure26.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3026,815,733 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001819790-24-000111.Report this figure30.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3030,622,440 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001819790-24-000129.Report this figure35.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3135,300,655 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001819790-25-000078.Report this figure37.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3037,823,233 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001819790-25-000108.Report this figure38.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3038,381,968 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure39.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3139,345,359 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure42.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3042,360,452 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure42.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3042,607,717 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001819790-25-000121.Report this figure43.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3142,956,973 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001819790-26-000038.Report this figure43.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3043,393,643 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure

Shares outstanding: 43.88mShares outstanding, period not labelled, at 2026-07-3043,882,996 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001819790-26-000064.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.